Cargando…
225. Dalbavancin Usage in Patients Who Inject Drugs (PWID)
BACKGROUND: Dalbavancin is a lipoglycopeptide antibiotic approved for the treatment of acute bacterial skin and skin structure infections (ABSSSI) secondary to gram-positive organisms. Given its long half-life, there has been increasing off-label use for other indications: osteomyelitis, joint infec...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678589/ http://dx.doi.org/10.1093/ofid/ofad500.298 |